DarioHealth Corp. (NASDAQ:DRIO), a leading global digital health company with mobile health and big data solutions, today
announced that it has entered into a strategic agreement with CCS Medical and their LivingConnected clinical program.
Through this strategic agreement and proprietary API, DarioHealth is partnering with CCS Medical by providing live data access
to CCS Medical for patients that join the LivingConnected clinical program using the DarioHealth native smartphone app. In
addition, CCS Medical will take an active role in the DarioHealth Insurance Provider Network, thereby further growing DarioHealth's
expansion into the insurance reimbursement option launched earlier this year.
The LivingConnected program is a cellular-enabled diabetes management program designed to give diabetes patients access to live
monitoring and guidance when they have an adverse reading or trend in their blood sugar levels.
The goal of LivingConnected is to help patients manage their diabetes in real time, which helps prevent complications and
improve their quality of life. Results of live readings can be shared with others, allowing immediate health coaching from
Registered Nurses and Certified Diabetes Educators. Ongoing reports and education are also part of the coordination of the
patient's care.
Sean Browne, Chief Revenue Officer of CCS Medical, commented, "We are enthusiastic about the DarioHealth partnership and expect
significant growth in this segment of our business, due to the innovative nature of the DarioHealth technology."
Erez Raphael, Chairman and CEO of DarioHealth, commented, "CCS Medical is a leading provider of home medical supplies for
patients with chronic conditions, including diabetes. This is a natural fit for us as it further strengthens our position in the
U.S. market, because through our API, CCS Medical can offer additional value-added services to their customers. With this
partnership, we aim to continue our market expansion, which is critical for DarioHealth as it aims to ramp up sales and market
share in the second half of the year."
Following the development of DarioHealth's proprietary API, DarioHealth expects to enter into further strategic alliances over
the coming months.
About CCS Medical's LivingConnected Program
CCS Medical, a leader with over 20 years of industry experience, is a leading provider of quality medical supplies for patients
with chronic conditions. CCS Medical's LivingConnected program is an innovative mobile health solution, which enables those with
diabetes to live healthier lives. This program brings needed visibility to the diabetic population and the exorbitant costs
associated with this chronic disease. Through key elements of healthy living, the LivingConnected solution effectively manages the
rising costs of diabetes. For more information on CCS Medical, visit https://ccsmed.com.
About DarioHealth Corp.
DarioHealth Corp. is a leading global digital health company serving tens of thousands of users with dynamic mobile health
solutions. We believe people deserve the best tools to manage their treatment, and harnessing big data, we have developed a unique
way for our users to analyze and personalize their diabetes management. With our smart diabetes solution, users have direct access
to track and monitor all facets of diabetes, without having the disease slow them down. The acclaimed Dario(TM) Blood Glucose
Monitoring System all-in-one blood glucose meter and native smartphone app gives users an unrivaled method for self-diabetes
management. DarioHealth is headquartered in Caesarea, Israel with a regional office in Burlington, Massachusetts. For more
information, visit http://mydario.investorroom.com/.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and partners of DarioHealth Corp. (the "Company") related thereto contain
or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements
that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the
foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend,"
"could," "estimate," or "continue" are intended to identify forward-looking statements. For example, when the Company describes its
growth plans and prospects, its plans for the second half of 2017, and its expectations for further strategic alliances, it is
using forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and
could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors
that may affect the Company's results include, but are not limited to, regulatory approvals, product demand, market acceptance,
impact of competitive products and prices, product development, commercialization or technological difficulties, the success or
failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash
resources. Additional factors that could cause or contribute to differences between the Company's actual results and
forward-looking statements include, but are not limited to, those risks discussed in the Company's filings with the U.S. Securities
and Exchange Commission. Readers are cautioned that actual results (including, without limitation, the timing for and results of
the Company's commercial and regulatory plans for Dario(TM)) may differ significantly from those set forth in the forward-looking
statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by applicable law.
CCS Medical Corporate and Media Contact
Jennifer Perry
Director, Marketing
jennifer.perry@ccsmed.com
1-972-773-4380
CCS Medical LivingConnected Contact
Darrell Meador
VP, Group Sales
darrell.meador@ccsmed.com
1-800-234-5593
DarioHealth Corporate and Media Contact
Shmuel Herschberg
Marketing Director
shmuel@mydario.com
1-914-775-5548
DarioHealth Investor Relations Contact
Hayden IR
Stephen Hart
DRIO@HaydenIR.com
1-646-415-8972
